Safety of Parenteral Hydroxypropyl β‐Cyclodextrin
Open Access
- 1 February 1995
- journal article
- case report
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 84 (2) , 222-225
- https://doi.org/10.1002/jps.2600840220
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Hydroxypropylcyclodextrins in Parenteral use. I: Lipid Dissolution and Effects on Lipid Transfers in VitroJournal of Pharmaceutical Sciences, 1992
- Hydroxypropylcyclodextrins in Parenteral Use. II: Effects on Transport and Disposition of Lipids in Rabbit and HumansJournal of Pharmaceutical Sciences, 1992
- Mechanism of transfer of LDL-derived free cholesterol to HDL subfractions in human plasmaBiochemistry, 1990
- An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys☆International Journal of Pharmaceutics, 1990
- Severe hypervitaminosis A in siblings: Evidence of variable tolerance to retinol intakeThe Journal of Pediatrics, 1987
- Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugsInternational Journal of Pharmaceutics, 1986
- Amorphous Water-Soluble Derivatives of Cyclodextrins: Nontoxic Dissolution Enhancing ExcipientsJournal of Pharmaceutical Sciences, 1985
- Rescue from hypervitaminosis A or potentiation or retinoid toxicity by different modes of cyclodextrin administrationLife Sciences, 1983
- Cholesterol desorption from clusters of phosphatidylcholine and cholesterol in unilamellar vesicle bilayers during lipid transfer or exchangeBiochemistry, 1982
- Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase.Proceedings of the National Academy of Sciences, 1981